EUVIMED · CrossrefJournal
Therapeutic Advances in Rare Disease
ISSN 2633-0040 · SAGE Publications
Latest articles
Eneboparatide induces prolonged 24-hour PTH 1 receptor activation
First bone marrow transplantation for mucopolysaccharidosis type I in Vietnam: a case report
2000–2025: Emerging therapies in primary mitochondrial disease: A structured review, horizon scan, and roadmap for the future
Patients’ lived experience of thymidine kinase 2 deficiency: the online survey-based assessment of TK2d patient perspectives study
Treatment outcomes maintained in Hunter syndrome patients: a case series on switching from idursulfase to idursulfase beta in Belarus
Cancer prevalence in primary mitochondrial disease patients and their families
TANGO2 Research Foundation Poster Abstracts 2026 - TANGO2 Family Conference - Disney’s Coronado Springs Resort - June 28 - 30, 2026
A novel therapy for pyridoxine-dependent epilepsy due to biallelic pathogenic variants in ALDH7A1 : secondary mitochondrial energy deficiency and improvements of neurodevelopmental outcomes on triheptanoin treatment
Challenges and opportunities for the use of telehealth in rare disease diagnosis, treatment, research, and education: key opinion leader interviews by the IRDiRC telehealth task force
Reliability assessment using the test–retest method and minimal important changes in the Adult Fabry Disease Quality of Life Scale
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Lysosomal storage diseases in North America: a comprehensive review of enzyme therapies and unmet needs
From roadmap to a sustainable end-to-end individualized therapy pathway
Roadmap to advance therapeutics for SYNGAP1 -related disorder: a patient organization perspective from SynGAP Research Fund
Establishing resources and increasing awareness to advance research on Dentatorubral-pallidoluysian atrophy toward a treatment: a patient organization perspective
Understanding dentatorubral-pallidoluysian atrophy (DRPLA) symptoms and impacts on daily life: a qualitative interview study with patients and caregivers
The growing research toolbox for SLC13A5 citrate transporter disorder: a rare disease with animal models, cell lines, an ongoing Natural History Study and an engaged patient advocacy organization
The role of the TSC Alliance in advancing therapy development: a patient organization perspective
The small steps that lead to big impact: translating therapeutics from idea to reality for the CDKL5 deficiency disorder community
Congenital insensitivity to pain with anhidrosis: a literature review and the advocacy for stem cell therapeutic interventions
Emerging roles and opportunities for rare disease patient advocacy groups
Clinical evidence of interventions assessed in Friedreich ataxia: a systematic review
Keratoconus: cross-linking the window of the eye
Therapeutic and diagnostic advances in Stickler syndrome
Introducing Therapeutic Advances in Rare Disease
Congenital cataract: a guide to genetic and clinical management
Role of red free imaging, retinal reflectance and fundus autofluorescence in Bietti crystalline dystrophy: case report
A review of the treatment landscape in paroxysmal nocturnal haemoglobinuria: where are we now and where are we going?
Conservative management of a fourth ventricular epidermoid in a patient with Gardner syndrome
Understanding the perspective of patients with pulmonary arterial hypertension: looking beyond health-related quality of life
EUVIMED